Definitive Contract HHSO100201500009C
Award Date 6/2/15
Potential Completion Date 8/31/22
Potential Value $12M
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost Plus Fixed Fee
Place of Performance
Fountain Hill, PA 18015, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Orasure Technologies Inc. (Orasure) is for the procurement of OraQuick Ebola Rapid Antigen Tests by the Centers for Disease Control and Prevention (CDC). The definitive contract, valued at $278,620.89, was awarded on August 1, 2016 with a completion date of November 30, 2016. This contract does not have a set-aside designation, indicating it was awarded through full and open competition. Orasure is a global manufacturer of oral fluid diagnostic products and...
- The U.S. Department of Health and Human Services (HHS) awarded a $240,491.71 firm-fixed-price purchase order to OraSure Technologies Inc. (doing business as OraSure) for the acquisition of Filovirus Point-of-Care (POC) diagnostic tests. The award, which has no set-aside designation, supports the procurement of a minimum of 8,500 lateral flow, rapid antigen tests for Ebola virus that can be used on oral fluids from cadavers and have a nine-month shelf life. OraSure is the only current provider...
- This federal contract award to OraSure Technologies Inc. by the Biomedical Advanced Research and Development Authority (BARDA), an agency within the U.S. Department of Health and Human Services (HHS), is for the procurement of point-of-care diagnostic tests to detect the Ebola virus in cadavers. The purpose is to acquire handheld, lateral flow, rapid antigen tests that are either FDA Emergency Use Authorized or 510(k) cleared, and able to sample oral fluid from cadavers of individuals...
- This federal contract award was made by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the Department of Health and Human Services (HHS), to Orasure Technologies Inc., a for-profit manufacturer of medical diagnostic products. The contract is for the development and production of the OraQuick Zika Point-of-Care Test, with a ceiling value of $4,969,092.67. The contract is a Definitive Contract with a Cost Plus Fixed Fee pricing type and an...
- This definitive contract awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to Orasure Technologies Inc. is valued at $710,310 to support the development of a rapid antigen test for COVID-19. The contract was awarded under Special Instructions 019 of the Easy Broad Agency Announcement BAA-20-100-SOL-0002 and will deliver research and development efforts towards a host-directed therapeutic to aid long-term outcomes from lung...
- The U.S. Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, awarded a $5,746,950.00 firm-fixed-price definitive contract to Orasure Technologies Inc. for the delivery of over-the-counter (OTC) COVID-19 tests. The contract has a performance period through March 19, 2025 and was not set aside for any special business designation. Orasure, a manufacturer of diagnostic products including rapid tests for HIV, Ebola, and COVID-19, has been a...
- Orasure Technologies Inc., doing business as Orasure, has been awarded a definitive contract valued at $540,609 by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response. Under this firm fixed price contract, Orasure will conduct research and development of an antibody test to support the Coronavirus COVID-19 National Interest Action Code and COVID-19 - R & D OF A RAPID ANTIGEN TEST major program. Performance will take place in Fountain...
- This federal contract award, valued at $388,440,000.00, was issued by the Defense Logistics Agency Troop Support Medical to Orasure Technologies Inc., a for-profit manufacturer of diagnostic medical testing products. The contract is for the delivery of InteliSwab COVID-19 Rapid Test Kits, a type of over-the-counter COVID-19 diagnostic test. The contract has an ultimate completion date of October 6, 2022 and was awarded on October 20, 2021. No set-aside designation was used for this contract....
- This is a delivery order awarded by the Centers for Disease Control and Prevention (CDC) under the Safety and Healthcare Epidemiology Prevention Research Development (SHEPheRD) indefinite delivery, indefinite quantity (IDIQ) contract. The contract was awarded to Health Core, Inc., a for-profit organization, to provide services related to the Ebola virus response, as indicated by the solicitation number "RFTOP 2015-010 AUR EBOLA". The contract has a firm fixed price of $491,954.00 and a...
- Orasure Technologies Inc., doing business as Orasure, has been awarded a definitive contract valued at $78.1 million by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response (HHS ASPR). The firm fixed price contract is for COVID 19 DIB FOR ORASURE TECHNOLOGIES COVID-19 HOME TEST INDUSTRIAL BASE EXPANSION and will support the expansion of Orasure's COVID-19 home test production capacity through March 2024. Performance will take place in...